Hantz Financial Services’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
Hantz Financial Services's BIO Position: Q3 2026 in Review
Hantz Financial Services increased its Bio-Rad Laboratories Class A (BIO) stake by 7.6% in Q3 2026, buying an estimated $28.3K and bringing the position to 1,142 shares worth $431K. The position accounts for 0.01% of the portfolio, ranked #784.
Hantz Financial Services first reported a position in BIO in Q1 2020 and has held it in 23 quarters since. 417 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- Hantz Financial Services held 1,142 shares of Bio-Rad Laboratories Class A worth $431K as of Q3 2026.
- Hantz Financial Services bought 81 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $28.3K.
- Bio-Rad Laboratories Class A made up 0.01% of Hantz Financial Services's portfolio in Q3 2026, its #784 holding.
- Hantz Financial Services first reported a position in Bio-Rad Laboratories Class A in Q1 2020 and has held it in 23 quarters since.
- 417 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on Hantz Financial Services's 13F filing for Q3 2026, filed 9 Nov 2026.